Loading...
Pharmacokinetics of Zanamivir following Intravenous Administration to Subjects with and without Renal Impairment
Intravenous zanamivir is in clinical development for the treatment of influenza in hospitalized patients, many of whom have renal impairment. This open-label study evaluated zanamivir pharmacokinetics and clinical safety following a single 100-mg intravenous infusion dose in subjects with impaired r...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3697365/ https://ncbi.nlm.nih.gov/pubmed/23587959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02330-12 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|